Tenaya Therapeutics, Inc. Common Stock (TNYA) is a publicly traded Healthcare sector company. As of July 15, 2026, TNYA trades at $0.86 with a market cap of $181.52M and a P/E ratio of -1.85. TNYA moved +2.90% today. Year to date, TNYA is +21.52%; over the trailing twelve months it is +21.54%. Its 52-week range spans $0.36 to $4.01. Analyst consensus is strong buy with an average price target of $10.33. Rallies surfaces TNYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TNYA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.86 |
| Market Cap | $181.52M |
| P/E Ratio | -1.85 |
| EPS | $-0.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.01 |
| 52-Week Low | $0.36 |
| Volume | 1.71M |
| Avg Volume | 0 |
| Revenue (TTM) | $225.00K |
| Net Income | $-83.00M |
| Gross Margin | 0.00% |
7 analysts cover TNYA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.33.